Alpha 2.0
Login Register
» Articles » PMID: 34042980

BCMA CARs in Multiple Myeloma: Room for More?

Overview
Journal Blood
Publisher Elsevier
Specialty Hematology
Date 2021 May 27
PMID 34042980
Citations 2
Authors
Lydia Sarah Hui Lee
Kwee L Yong
Affiliations
Soon will be listed here.
Citing Articles

Equecabtagene Autoleucel in Patients With Relapsed or Refractory Multiple Myeloma: The FUMANBA-1 Nonrandomized Clinical Trial.

Li C, Zhou K, Hu Y, Zou D, Chen L, Chen B JAMA Oncol. 2024; .

PMID: 39509090 PMC: 11544552. DOI: 10.1001/jamaoncol.2024.4879.

LILRB4 represents a promising target for immunotherapy by dual targeting tumor cells and myeloid-derived suppressive cells in multiple myeloma.

Gong L, Sun H, Liu L, Sun X, Fang T, Yu Z Haematologica. 2024; 109(11):3650-3669.

PMID: 38813706 PMC: 11532705. DOI: 10.3324/haematol.2024.285099.